A Virtual Intervention to Improve Medication Adherence in Pediatric Cancer: MedSupport

NCT ID: NCT05150028

Last Updated: 2024-09-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

16 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-04-11

Study Completion Date

2024-06-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To develop a cancer center level practice intervention to promote treatment adherence and reduce outcome disparities in pediatric cancer survivors

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To conduct a pilot study to assess the feasibility and acceptability of the Social Determinants of Adherence intervention

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Medication Adherence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention - Pediatric parent/caregiver

Questionnaires along with educational videos

Group Type EXPERIMENTAL

Patient participation

Intervention Type BEHAVIORAL

Questionnaire

Clinicians

Will complete pre and post survey about medication education practices

Group Type EXPERIMENTAL

Clinician barrier reports

Intervention Type OTHER

How many times a 7 question Survey on medication education practices is opened

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Patient participation

Questionnaire

Intervention Type BEHAVIORAL

Clinician barrier reports

How many times a 7 question Survey on medication education practices is opened

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Parents/caregivers of pediatric patients must meet the following criteria to be eligible:

* Parents/guardians of child that has been diagnosed with any cancer.
* Parents/guardians of child with any cancer between age 0 and 18.
* Parents/guardians of child on home-based oral anti-cancer therapy or supportive care therapy.
* The clinician for the family agrees to participate in the study.

Exclusion Criteria

* Participants will be excluded from this study if unwilling or unable to complete the assessment in English
Minimum Eligible Age

1 Year

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Roswell Park Cancer Institute

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Elizabeth Bouchard, MD

Role: PRINCIPAL_INVESTIGATOR

Roswell Park Comprehensive Cancer Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Roswell Park Cancer Institute

Buffalo, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

I 2048021

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.